Ausgabe 10/2010
Inhalt (26 Artikel)
The options for the future production of the medical isotope 99Mo
Steven C. van der Marck, Arjan J. Koning, Kevin E. Charlton
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
Sally F. Barrington, Wendi Qian, Edward J. Somer, Antonella Franceschetto, Bruno Bagni, Eva Brun, Helén Almquist, Annika Loft, Liselotte Højgaard, Massimo Federico, Andrea Gallamini, Paul Smith, Peter Johnson, John Radford, Michael J. O’Doherty
Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy
Laura Gilardi, Concetta De Cicco, Marco Colleoni, Anna Cardillo, Emilia Montagna, Silvia Dellapasqua, Viviana Galimberti, Vincenzo Bagnardi, Giovanni Paganelli
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters
Timm Denecke, Patrick Hundsdörfer, Daniel Misch, Ingo G. Steffen, Stefan Schönberger, Christian Furth, Michail Plotkin, Juri Ruf, Hubertus Hautzel, Brigitte Stöver, Regine Kluge, Uta Bierbach, Sylke Otto, James F. Beck, Christiane Franzius, Günter Henze, Holger Amthauer
Seasonal variation in the effect of constant ambient temperature of 24°C in reducing FDG uptake by brown adipose tissue in children
Katherine A. Zukotynski, Frederic H. Fahey, Stephen Laffin, Royal Davis, S. Ted Treves, Frederick D. Grant, Laura A. Drubach
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model
Bernd J. Krause, Michael Souvatzoglou, Ken Herrmann, Axel W. Weber, Tibor Schuster, Andreas K. Buck, Roman Nawroth, Gregor Weirich, Uwe Treiber, Hans-Jürgen Wester, Sibylle I. Ziegler, Reingard Senekowitsch-Schmidtke, Markus Schwaiger
177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide
Daniel Hubble, Grace Kong, Michael Michael, Val Johnson, Shakher Ramdave, Rodney John Hicks
Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib
Bernd Kasper, Antonia Dimitrakopoulou-Strauss, Ludwig G. Strauss, Peter Hohenberger
A fast cardiac gamma camera with dynamic SPECT capabilities: design, system validation and future potential
Moshe Bocher, Ira M. Blevis, Leonid Tsukerman, Yigal Shrem, Gil Kovalski, Lana Volokh
Real-time breath-hold triggering of myocardial perfusion imaging with a novel cadmium-zinc-telluride detector gamma camera
Ronny R. Buechel, Aju P. Pazhenkottil, Bernhard A. Herzog, Lars Husmann, René N. Nkoulou, Irene A. Burger, Ines Valenta, Christophe A. Wyss, Jelena R. Ghadri, Philipp A. Kaufmann
99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model
David R. Okada, Zhonglin Liu, Gerald Johnson III, Delia Beju, Ban An Khaw, Robert D. Okada
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG
Anu Autio, Tiina Ujula, Pauliina Luoto, Satu Salomäki, Sirpa Jalkanen, Anne Roivainen
Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein
Florian Kampmeier, Judith Niesen, Alexander Koers, Markus Ribbert, Andreas Brecht, Rainer Fischer, Fabian Kießling, Stefan Barth, Theo Thepen
Activation of P-glycoprotein (Pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled PET tracer
Oliver Thews, Wolfgang Dillenburg, Marco Fellner, Hans-Georg Buchholz, Nicole Bausbacher, Mathias Schreckenberger, Frank Rösch
Biodistribution and radiation dosimetry of a positron emission tomographic ligand, 18F-SP203, to image metabotropic glutamate subtype 5 receptors in humans
Yasuyuki Kimura, Fabrice G. Siméon, Jun Hatazawa, P. David Mozley, Victor W. Pike, Robert B. Innis, Masahiro Fujita
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients
Astrid A. M. van der Veldt, N. Harry Hendrikse, Egbert F. Smit, Martien P. J. Mooijer, Anneloes Y. Rijnders, Winald R. Gerritsen, Jacobus J. M. van der Hoeven, Albert D. Windhorst, Adriaan A. Lammertsma, Mark Lubberink
A review on the clinical uses of SPECT/CT
Giuliano Mariani, Laura Bruselli, Torsten Kuwert, Edmund E. Kim, Albert Flotats, Ora Israel, Maurizio Dondi, Naoyuki Watanabe
FDG-PET/CT in infections: the imaging method of choice?
Andor W. J. M. Glaudemans, Alberto Signore
FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients
Katharina Dalus, Gundula Rendl, Lukas Rettenbacher, Christian Pirich
Post-traumatic biliobronchial fistula demonstrated on hepatobiliary scintigraphy with SPECT/CT
Anish Bhattacharya, Koramadai Karuppuswamy Kamaleshwaran, Chidambaram Natarajan Balasubramaniam Harisankar, Kuruva Manohar, Mohammed Labeeb Abrar, Bhagwant Rai Mittal
Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma
Jin-Suk Kim, Young Jin Jeong, Myung-Hee Sohn, Seok Tae Lim, Dong Wook Kim, Hwan-Jeong Jeong, Jae-Yong Kwak, Chang-Yeol Yim
NEW! EANM PET/CT Advanced Course—successfully launched
EANM YIM 2010—Report
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
Irene Virgolini, Valentina Ambrosini, Jamshed B. Bomanji, Richard P. Baum, Stefano Fanti, Michael Gabriel, Nikolaos D. Papathanasiou, Giovanna Pepe, Wim Oyen, Clemens De Cristoforo, Arturo Chiti